These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2010-022486-10 A multicentre, randomised, double-blind, placebo-controlled, dose-finding phase II clinical study to evaluate the efficacy of two different doses of MT-102 administered over a sixteen week period in s... not-yet-due
Exempt, with results 2012-001067-79 A Clinical Study Of ColoAd1 Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorecta... 2016-04-29 not-yet-due
Exempt, with results 2013-001276-38 A Clinical Study Of ColoAd1 Administered Intraperitoneally: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer Estudio clĂ­nico de ColoAd1 (INN: EnAd) administrado por... not-yet-due
Reported results 2016-004777-40 A multicentre observational study for the long term follow up of subjects that have been treated with enadenotucirev during interventional clinical trial 2020-09-07 due-trials